adenosine monophosphate has been researched along with Multiple Sclerosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, CC; Li, J; Liu, HH; Wang, J; Yin, XD | 1 |
| Bjelobaba, I; Lavrnja, I; Mostarica-Stojkovic, M; Nedeljkovic, N; Pekovic, S; Stojiljkovic, M; Stosic-Grujicic, S | 1 |
| Dowd, PM; Kilfeather, S; Kirby, JD; Lima, DR; Turner, P | 1 |
| Karlov, VA; Kitaeva, LV; Kozlov, SA; Savin, AA; Seleznev, AN | 1 |
1 review(s) available for adenosine monophosphate and Multiple Sclerosis
| Article | Year |
|---|---|
COVID-19 illness and autoimmune diseases: recent insights.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Arthritis, Rheumatoid; Autoimmune Diseases; Azetidines; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Dendritic Cells; Humans; Immune System; Immunity, Innate; Immunization, Passive; Inflammatory Bowel Diseases; Killer Cells, Natural; Lupus Erythematosus, Systemic; Monocytes; Multiple Sclerosis; Purines; Pyrazoles; Sulfonamides | 2021 |
3 other study(ies) available for adenosine monophosphate and Multiple Sclerosis
| Article | Year |
|---|---|
Time-course changes in ectonucleotidase activities during experimental autoimmune encephalomyelitis.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Apyrase; Cell Membrane; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Multiple Sclerosis; Rats; Rats, Inbred Strains; Spinal Cord; Time Factors | 2009 |
Prostacyclin increases cyclic-nucleotide responsiveness of lymphocytes from patients with systemic sclerosis.
Topics: Adenosine Monophosphate; Adult; Aged; Epoprostenol; Female; Humans; Isoproterenol; Lymphocytes; Middle Aged; Multiple Sclerosis; Prostaglandins; Raynaud Disease | 1980 |
[Russian preparations for the metabolic therapy of multiple sclerosis patients].
Topics: Adenosine Monophosphate; Adult; Antioxidants; Cobamides; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Pantothenic Acid; Quaternary Ammonium Compounds; Remission Induction; Russia; Vitamins | 1995 |